Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-EN Version v7-EN
Language English English
Date Updated 2021-10-14 2021-10-06
Drug Identification Number 02333619 02333619
Brand name GLUCAGEN GLUCAGEN
Common or Proper name GLUCAGEN 1 MG GLUCAGEN 1 MG
Company Name NOVO NORDISK CANADA INC NOVO NORDISK CANADA INC
Ingredients GLUCAGON GLUCAGON
Strength(s) 1MG 1MG
Dosage form(s) POWDER FOR SOLUTION KIT POWDER FOR SOLUTION KIT
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 1MG 1 x 1MG
ATC code H04AA H04AA
ATC description GLYCOGENOLYTIC HORMONES GLYCOGENOLYTIC HORMONES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-10-06 2021-10-06
Actual start date 2021-10-06 2021-10-06
Estimated end date 2021-10-13 2021-10-13
Actual end date 2021-10-13
Shortage status Resolved Anticipated shortage
Company comments Resolved, product is available Demand increase for the drug and Delay in Shipping of the drug. Glucagen® in the Hypokit format remains available as an alternative. The only difference between Glucagen® and Glucagen® Hypokit is in the packaging and format of the solvent.
Health Canada comments